Co-expression of SOX9 and SOX10 during melanocytic differentiation in vitro
- 1 August 2005
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 308 (1), 222-235
- https://doi.org/10.1016/j.yexcr.2005.04.019
Abstract
No abstract availableKeywords
Funding Information
- Royal Brisbane and Women's Hospital Foundation
- University of Queensland
- Australian Research Council (DP0451738)
This publication has 48 references indexed in Scilit:
- Transcription factors Sox8 and Sox10 perform non-equivalent roles during oligodendrocyte development despite functional redundancyDevelopment, 2004
- Suppression of growth and tumorigenicity in the prostate tumor cell line M12 by overexpression of the transcription factor SOX9Oncogene, 2004
- Human Melanoblasts in Culture: Expression of BRN2 and Synergistic Regulation by Fibroblast Growth Factor-2, Stem Cell Factor, and Endothelin-3Journal of Investigative Dermatology, 2003
- The POU proteins Brn-2 and Oct-6 share important functions in Schwann cell developmentGenes & Development, 2003
- Sox10 Is an Active Nucleocytoplasmic Shuttle Protein, and Shuttling Is Crucial for Sox10-Mediated TransactivationMolecular and Cellular Biology, 2002
- Mutations of the BRAF gene in human cancerNature, 2002
- The Transcription Factors SOX9 and SOX10 Are Vitiligo Autoantigens in Autoimmune Polyendocrine Syndrome Type IJournal of Biological Chemistry, 2001
- Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related geneNature, 1994
- Molecular Basis of Human PiebaldismJournal of Investigative Dermatology, 1994
- In Vivo and In Vitro Expression of Octamer Binding Proteins in Human Melanoma Metastases, Brain Tissue, and FibroblastsPigment Cell Research, 1993